Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines. (2023)

First Author: Pather S
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2023.1232965

PubMed Identifier: 37377964

Publication URI: http://europepmc.org/abstract/MED/37377964

Type: Journal Article/Review

Volume: 14

Parent Publication: Frontiers in immunology

ISSN: 1664-3224